Bravo, I. (2018). Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study’. Br J Cancer.
Style de citation ChicagoBravo, Isabel. "Comment On ‘Efficacy of Stereotactic Body Radiotherapy in Oligorecurrent and in Oligoprogressive Prostate Cancer: New Evidence From a Multicentric Study’." Br J Cancer 2018.
Style de citation MLABravo, Isabel. "Comment On ‘Efficacy of Stereotactic Body Radiotherapy in Oligorecurrent and in Oligoprogressive Prostate Cancer: New Evidence From a Multicentric Study’." Br J Cancer 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.